Concert Pharmaceutic
(CNCE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 32,578 | 7,902 | 1,077 | 10,505 | 143,891 |
| Gross Profit | 32,578 | 7,902 | 1,077 | 10,505 | 143,891 |
| Operating Expenses | 110,086 | 80,549 | 80,092 | 66,089 | 51,242 |
| Operating Income | -77,508 | -72,647 | -79,015 | -55,584 | 92,649 |
| Interest Expense | 0 | 0 | 0 | 0 | 815 |
| Other Income | -2,543 | -2,204 | 849 | -127 | 3,505 |
| Pre-tax Income | -80,051 | -74,851 | -78,166 | -55,711 | 95,339 |
| Income Tax | N/A | -85 | N/A | 313 | -300 |
| Net Income Continuous | -80,051 | -74,766 | -78,166 | -56,024 | 95,639 |
| Net Income | $-80,051 | $-74,766 | $-78,166 | $-56,024 | $95,639 |
| EPS Basic Total Ops | -2.33 | -2.40 | -3.29 | -2.40 | 4.20 |
| EPS Basic Continuous Ops | -2.33 | -2.40 | -3.29 | -2.40 | 4.22 |
| EPS Diluted Total Ops | -2.33 | -2.40 | -3.29 | -2.40 | 4.06 |
| EPS Diluted Continuous Ops | -2.33 | -2.40 | -3.29 | -2.40 | 4.08 |
| EPS Diluted Before Non-Recurring Items | -2.27 | -2.40 | -3.29 | -2.40 | 4.08 |
| EBITDA(a) | $-75,994 | $-70,994 | $-78,364 | $-55,509 | $93,589 |